Cargando…
Early Treatment of Interleukin-33 can Attenuate Lupus Development in Young NZB/W F1 Mice
Interleukin-33 (IL-33), a member of the IL-1 cytokine family, has been recently associated with the development of autoimmune diseases, including systemic lupus erythematosus (SLE). IL-33 is an alarmin and a pleiotropic cytokine that affects various types of immune cells via binding to its receptor,...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696801/ https://www.ncbi.nlm.nih.gov/pubmed/33182616 http://dx.doi.org/10.3390/cells9112448 |